Showing results (101-110 of 415) with videos related to
Sort By:
Pageof 42
Blood Advances|April 4, 2019
Germline deletion of ETV6 in familial acute lymphoblastic leukemiaEvadnie Rampersaud, David S Ziegler, Ilaria Iacobucci, et al.Breast Cancer Research : BCR|March 4, 2005
The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Antonis C Antoniou, David L Duffy, et al.Haematologica|February 11, 2021
Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemiaMarion K Mateos, Glenn M Marshall, Pasquale M Barbaro, et al.Epigenetics & Chromatin|May 30, 2018
Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X TenShalima S Nair, Phuc-Loi Luu, Wenjia Qu, et al.Journal of the National Cancer Institute|February 7, 2002
Dominant negative ATM mutations in breast cancer familiesGeorgia Chenevix-Trench, Amanda B Spurdle, Magtouf Gatei, et al.Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|May 22, 2009
Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortiumSharon E Johnatty, Jonathan Beesley, Xiaoqing Chen, et al.Breast Cancer Research and Treatment|February 23, 2018
Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patientJulie Johnson, Darrell C Bessette, Jodi M Saunus, et al.International Journal of Epidemiology|December 25, 2019
A Mendelian randomization analysis of circulating lipid traits and breast cancer riskAlicia Beeghly-Fadiel, Nikhil K Khankari, Ryan J Delahanty, et al.Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.Human Molecular Genetics|March 26, 2015
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility lociSimon G Coetzee, Howard C Shen, Dennis J Hazelett, et al.Pageof 42